Rankings
▼
Calendar
HROW FY 2021 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
FY 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$72M
+48.3% YoY
Gross Profit
$54M
74.9% margin
Operating Income
$2M
2.2% margin
Net Income
-$18M
-24.8% margin
EPS (Diluted)
$-0.69
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
-$23M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$98M
Total Liabilities
$87M
Stockholders' Equity
$11M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$72M
$49M
+48.3%
Gross Profit
$54M
$34M
+57.7%
Operating Income
$2M
$385,000
+319.2%
Net Income
-$18M
-$3M
-436.4%
← Q4 2020
All Quarters
Q1 2021 →